Effects of vehicles and enhancers on transdermal delivery of clebopride

Archives of Pharmacal Research

Volumn 30, Issue 9, 2007, Pages 1155-1161

  Rhee, Yun Seok ^a   Huh, Jai Yong ^a   Park, Chun Woong ^a   Nam, Tae Young ^a   Yoon, Koog Ryul ^a   Chi, Sang Cheol ^a   Park, Eun Seok ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Binary vehicle system; Clebopride; Enhancer; Skin permeation; Vehicle

Indexed keywords

EID: 34848844301     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02980252     Document Type: Article

References (42)

1. Aboofazeli, R., Zia, H., and Needham, T. E., Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv., 9, 239-247 (2002).
2. Aungst, B. J., Rogers, N. J., and Shefter, E., Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm., 33, 225-234 (1986).
3. Barry, B. W., Dermatological Formulations, Marcel Dekker Inc., New York, pp. 49-94 (1983).
4. Barry, B. W., Yamane, M. A., and Williams, A. C., Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int. J. Pharm., 116, 237-251 (1995).
5. Calpena, A. C., Blanes, C., Moreno, J., Obach, R., and Domenech, J., A comparative in vitro study of transdermal absorption of antiemetics. J. Pharm. Sci., 83, 29-33 (1994).
6. Cha, B. J., Lee, E. D., Kim, W. B., Chung, S. J., Lee, M. H., and Shim, C. K., Enhanced skin permeation of a new capsaicin derivative (DA-5018) from a binary vehicle system composed of isopropyl myristate and ethoxydiglycol. Arch. Pharm. Res., 24(3), 224-228 (2001).
7. Chi, S. C., Park, E. S., and Kim, H., Effect of penetration enhancers on flurbiprofen permeation through rat skin. Int. J. Pharm., 126, 267-274 (1995).
8. Cleary, G. W., Transdermal Controlled Release Systems. Langer, R. S. and Wise, D. L. (Eds.), Medical applications of controlled release, CRC Press, Boca Raton, pp. 203-251 (1984).
9. Cooper, E. R., Increased skin permeability for lipophilic molecules. J. Pharm. Sci., 73, 1153-1156 (1984).
10. Cooper, E. R. and Patel, D. C., Practical considerations for topical drug formulations with and without enhancers. Osborne, D. W. and Amann, A. H. (Ed.), Topical drug delivery formulations, Marcel Dekker, Inc., New York, pp.1-12 (1990).
11. Gorukanti, S. R., Li, L., and Kim, K. H., Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation. Int. J. Pharm., 192, 159-172 (1999).
12. Goto, S., Uchida, T., Lee, C. K., Yasutake, T., and Zhang, J. B., Effect of various vehicles on ketoprofen permeation across excised hairless mouse skin. J. Pharm. Sci., 82, 1155-1159 (1993).
13. Gwak, H. S., Kim, S. U., and Chun, I. K., Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch. Pharm. Res., 25, 392-396 (2002).
14. Hadgraft, J., Pugh, J. W., and Wolff, H. M., Transdermal delivery of some anti-emetics. Int. J. Pharm., 123, 285-289 (1995).
15. Higuchi, T., Physical chemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem., 11, 85-97 (1960).
16. Hori, M., Satoh, S., Maibach, H. I., and Guy, R. H., Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro; Effect of enhancer lipophilicity. J. Pharm. Sci., 80, 32-35 (1991).
17. Jeans, C. W. and Heard, C. M., A therapeutic dose of primaquine can be delivered across excised human skin from simple transdermal patches. Int. J. Pharm., 189, 1-6 (1999).
18. Kaiho, F., Nomura, H., Makabe, E., and Kato, Y., Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG bases) through rat skin: Effects of fatty acid added to FAPG base. Chem. Pharm. Bull., 35, 2928-2934 (1987).
19. Kandimalla, K. K., Kanikkannan, N., and Singh, M., Optimization of a vehicle mixture for the transdermal delivery of melatonin using artificial neural networks and response surface method. J. Control. Release, 61(1-2), 71-82 (1999).
20. Karande, P., Jain, A., and Mitragotri, S., Insights into synergistic interactions in binary mixtures of chemical permeation enhancers for transdermal drug delivery. J. Control. Release, 115(1), 85-93 (2006).
21. Krishnaiah, Y. S., Satyanarayana, V., and Karthikeyan, R. S., Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharm. Sci., 5, 123-130 (2002).
22. Lee, C. K., Uchida, T., Noguchi, E., Kim, N.S., and Goto, S., Skin permeation enhancement of tegafur by ethanol/panasate 800 or ethanol/water binary vehicle and combined effect of fatty acids and fatty alcohols. J. Pharm. Sci., 82, 1155-1159 (1993).
23. Lee, C. K., Uchida, T., Kitagawa, K., Yagi, A., Kim, N. S., and Goto, S., Skin permeability of various drugs with different lipophilicity. J. Pharm. Sci., 83(4), 562-565 (1994).
24. Lenz, H. J., Hicking, W., Robinson, P. R., and Ehninger, G., Disposition of clebopride after intravenous administration. Drug Invest., 4, 47-50 (1992).
25. Leopold, C. S. and Lippold, B. C., Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo. J. Pharm. Sci., 84, 195-198 (1995).
26. Mayorga, P., Puisieux, F., and Couarraze, G., Formulation study of a transdermal delivery system of primaquine. Int. J. Pharm., 132, 71-79 (1996).
27. Murillo C. E. and Sanchez Romero, J. A., Double blind crossover study comparing clebopride and placebo in the prevention of nausea and vomiting in patients undergoing cancer chemotherapy. Curr. Ther. Res. Clin. Exp., 31, S61-S68 (1982).
28. Oh, H. J., Oh, Y. K., and Kim, C. K., Effects of vehicles and enhancers on transdermal delivery of melatonin. Int. J. Pharm., 212, 63-71 (2001).
29. Okamoto, H., Muta, K., Hashida, M., and Sezaki, H., Percutaneous penetration of acyclovir through excised hairless mouse and rat skin: Effect of vehicle and percutaneous penetration enhancer. Pharm. Res., 7, 64-68 (1990).
30. Panchagnula, R., Salve, P. S., Thomas, N.S., Jain, A. K., and Ramarao, P., Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int. J. Pharm., 219, 95-105 (2001).
31. Panchagnula, R., Desu, H., Jain, A., and Khandavilli, S., Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation. Farmaco, 60, 894-899 (2005).
32. Pfister, W. R. and Hsieh, D. S. T., Permeation enhancers compatible with transdermal drug delivery systems. Pharm. Technol., 14, 132-140 (1990).
33. Rojas, J., Falson, F., Couarraze, G., Francis, A., and Puisieux, F., Optimization of binary and ternary solvent systems in the percutaneous absorption of morphine base. S.T.P. Rharma Sci., 1, 70-75 (1991).
34. Sato, K., Sugibayashi, K., Morimoto, Y., Omiya, H., and Enomoto, N., Prediction of the in-vitro human skin permeability of nicorandil from animal data. J. Pharm. Pharmacol., 41, 379-383 (1989).
35. Sato, K., Mitsui, N., Hasegawa, T., Sugibayashi, K., and Morimoto, Y., Potential usefulness of solubility index for prediction of the skin permeation rate of 5-ISMN from pressure-sensitive adhesive tape. J. Control. Release, 73, 269-277 (2001).
36. Sugibayashi, K., Nemoto, M., and Morimoto, Y., Effect of several penetration enhancers on the percutaneous absorption of indomethacin in hairless rats. Chem. Pharm. Bull., 36, 1519-1528 (1988).
37. Suwanpidokkul, N., Thongnopnua, P., and Umprayn, K., Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS Pharm. Sci. Tech., 5, e48 (2004).
38. Takahashi, K., Tamagawa, S., Katagi, T., Yoshitomi, H., Kamada, A., Rytting, J. H., Nishihata, T., and Mizuno, N., In vitro transport of sodium diclofenac across rat abdominal skin: Effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull., 39, 154-158 (1991).
39. Thomas, N. S. and Panchagnula, R., Transdermal delivery of zidovudine: effect of vehicles on permeation across rat skin and their mechanism of action. Eur. J. Pharm. Sci., 18, 71-79 (2003).
40. Tonini, M., Cipollina, L., Poluzzi, E., Crema, F., Corazza, G. R., and De Ponti, F., Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment. Pharmacol. Ther., 19, 379-90 (2004).
41. Watkinson, A. C., Hadgraft, J., and Bye, A., Aspects of the transdermal delivery of prostaglandins. Int. J. Pharm., 74, 229-236 (1991).
42. Yazdanian, M. and Chen, E., The effect of diethylene glycol monoethyl ether as a vehicle for topical delivery of ivermectin. B.T. Gattefossé, 88, 69-70 (1995).